Lemonade and Early Death; Med School Rankings Delayed; $50 for OTC Narcan?

— Health news and commentary from around the Web gathered by MedPage Today staff

MedpageToday
Morning Break over illustration of a syringe, Covid virus, and DNA helix over a photo of green vegetation.

Note that some links may require subscriptions.

Soda, lemonade, and other sugary drinks were linked with premature death in people with type 2 diabetes. (The BMJ)

Senators are proposing a $35 cap on insulin for people with private insurance. (CNBC)

Oregon Gov. Tina Kotek (D) instructed state officials to start stocking up on the abortion drug mifepristone to accumulate a 3-year supply. (AP via ABC News)

A European organization that sells mifepristone online to Americans has seen a surge in demand since a federal judge overturned FDA approval of the drug. (NBC News)

Financial pressures and discrimination remain key roadblocks to increasing the number of Black and Hispanic doctors in the U.S. (NPR)

The FDA announced that Fresenius Kabi USA has recalled its Ivenix Infusion System because of a risk of fluid leak that may delay or interrupt treatment.

Envision Healthcare is considering a chapter 11 bankruptcy that would give control of the physician staffing company to creditors. (Wall Street Journal)

A study of seven states with high opioid-involved overdose mortality showed that depressive symptoms, depression, anxiety, adverse childhood experiences, and stressful life events were associated with a higher prevalence of postpartum substance use. (Morbidity and Mortality Weekly Report)

During 2022, Pfizer became the first drug company to surpass $100 billion in annual sales, fueled in large part by COVID vaccine sales. (Fierce Pharma)

In response to alleged discrepancies in data, U.S. News & World Report will delay the release of its annual lists of the nation's top law and medical schools. (Washington Post)

As part of the Biden administration's push for greater transparency in healthcare, HHS will make ownership data for all Medicare-certified hospice and home health agencies publicly available.

The Environmental Protection Agency proposed a ban on methylene chloride in all consumer situations and some commercial settings; the paint stripper, among its other uses, has been linked to health risks including death. (CBS News)

Racial disparities in stroke mortality widened during the pandemic. (Morbidity and Mortality Weekly Report)

Responding to Emergent BioSolutions' new price proposal for its over-the-counter naloxone (Narcan), experts say $50 is still too pricey. (Washington Post)

Kansas Gov. Laura Kelly (D) vetoed a set of anti-transgender measures that included a ban on gender-affirming care, but the Republican-controlled legislature readied for a vote to override the vetoes. (AP)

Nearly one in five (19%) transgender youth now live in states where gender-affirming care is banned, according to a new report from the Movement Advancement Project.

With a national ban on mentholated cigarettes on the horizon, R.J. Reynolds plans a market test in California for its "cool" and "crisp" cigarettes containing a synthetic coolant that mimics menthol. (Politico)

  • author['full_name']

    Charles Bankhead is senior editor for oncology and also covers urology, dermatology, and ophthalmology. He joined MedPage Today in 2007. Follow